Sign Up
Stories
Celyad Oncology Receives Notification
Share
Advancements in Cancer Treatment and Mar...
Advancements in Gene Editing and Cancer ...
Biocom California Appoints New Board Mem...
ANJESO Drug Insight and Market Forecast
Acquisition Progress Amid Safety Concern
Afya Limited Expands Medical Seats in Br...
Overview
API
Celyad Oncology SA receives a transparency notification from CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, exceeding 55% holding voting rights in Celyad Oncology.
Ask a question
How does this development reflect broader trends in the biotechnology industry and investment strategies?
How might the increased ownership by Fortress Investment Group LLC impact Celyad Oncology's operations and future plans?
What measures can Celyad Oncology take to address concerns regarding the ownership structure and maintain transparency?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage